Literature DB >> 15979036

An index case for the attenuated end of the mucopolysaccharidosis type VI clinical spectrum.

Doug A Brooks1, Gary J Gibson, Litsa Karageorgos, Leanne K Hein, Evelyn F Robertson, John J Hopwood.   

Abstract

Mucopolysaccharidosis type VI (MPS VI, Maroteaux-Lamy syndrome, McKusick #253200) is a lysosomal storage disorder that is caused by a deficiency in the lysosomal exohydrolase N-acetylgalactosamine-4-sulphatase (4-sulphatase, EC 3.1.6.1). We report a patient with no obvious clinical signs of MPS VI that has 5% of normal 4-sulphatase catalytic capacity. This patient represents an index case for the attenuated end of the MPS VI clinical spectrum.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15979036     DOI: 10.1016/j.ymgme.2005.02.008

Source DB:  PubMed          Journal:  Mol Genet Metab        ISSN: 1096-7192            Impact factor:   4.797


  12 in total

1.  Evaluation of oral manifestations of patients with mucopolysaccharidosis IV and VI: clinical and imaging study.

Authors:  Renata Quirino de Almeida-Barros; Paula Frassinetti Vasconcelos de Medeiros; Marcella Quirino de Almeida Azevedo; Adriana de Oliveira Lira Ortega; Angela Toshie Araki Yamamoto; Sheyla Kátia Lúcio Dornelas; Patrícia Meira Bento
Journal:  Clin Oral Investig       Date:  2017-03-19       Impact factor: 3.573

2.  Identification of eleven different mutations including six novel, in the arylsulfatase B gene in Iranian patients with mucopolysaccharidosis type VI.

Authors:  Rokhsareh Jafaryazdi; Sedigheh Shams; Anna Isaian; Aria Setoodeh; Shahram Teimourian
Journal:  Mol Biol Rep       Date:  2019-04-13       Impact factor: 2.316

Review 3.  Mucopolysaccharidosis VI.

Authors:  Vassili Valayannopoulos; Helen Nicely; Paul Harmatz; Sean Turbeville
Journal:  Orphanet J Rare Dis       Date:  2010-04-12       Impact factor: 4.123

4.  Mucopolysaccharidosis Type VI in a Great Dane Caused by a Nonsense Mutation in the ARSB Gene.

Authors:  Ping Wang; Carol Margolis; Gloria Lin; Elizabeth L Buza; Scott Quick; Karthik Raj; Rachel Han; Urs Giger
Journal:  Vet Pathol       Date:  2017-11-20       Impact factor: 2.221

5.  Segregation analysis in a family at risk for the Maroteaux-Lamy syndrome conclusively reveals c.1151G>A (p.S384N) as to be a polymorphism.

Authors:  Alessandra Zanetti; Elena Ferraresi; Luigi Picci; Mirella Filocamo; Rossella Parini; Camillo Rosano; Rosella Tomanin; Maurizio Scarpa
Journal:  Eur J Hum Genet       Date:  2009-03-04       Impact factor: 4.246

Review 6.  Cardiac disease in patients with mucopolysaccharidosis: presentation, diagnosis and management.

Authors:  Elizabeth A Braunlin; Paul R Harmatz; Maurizio Scarpa; Beatriz Furlanetto; Christoph Kampmann; James P Loehr; Katherine P Ponder; William C Roberts; Howard M Rosenfeld; Roberto Giugliani
Journal:  J Inherit Metab Dis       Date:  2011-07-09       Impact factor: 4.982

7.  Prevalence of anti-adeno-associated virus serotype 8 neutralizing antibodies and arylsulfatase B cross-reactive immunologic material in mucopolysaccharidosis VI patient candidates for a gene therapy trial.

Authors:  Rita Ferla; Pamela Claudiani; Marco Savarese; Karen Kozarsky; Rossella Parini; Maurizio Scarpa; Maria Alice Donati; Giovanni Sorge; John J Hopwood; Giancarlo Parenti; Simona Fecarotta; Vincenzo Nigro; Hatice Serap Sivri; Ans Van Der Ploeg; Generoso Andria; Nicola Brunetti-Pierri; Alberto Auricchio
Journal:  Hum Gene Ther       Date:  2015-03       Impact factor: 5.695

8.  First report of c. 1499G>C mutation in a 6-month-child with cystic fibrosis.

Authors:  Abbas Sahami; Nourkhoda Sadeghifard; Alireza Monsef; Hadi Peyman
Journal:  Indian J Hum Genet       Date:  2014-04

Review 9.  Diagnostic and treatment strategies in mucopolysaccharidosis VI.

Authors:  Filippo Vairo; Andressa Federhen; Guilherme Baldo; Mariluce Riegel; Maira Burin; Sandra Leistner-Segal; Roberto Giugliani
Journal:  Appl Clin Genet       Date:  2015-10-30

Review 10.  Attenuated osteoarticular phenotype of type VI mucopolysaccharidosis: a report of four patients and a review of the literature.

Authors:  Agnieszka Jurecka; Ekaterina Zakharova; Vera Malinova; Elena Voskoboeva; Anna Tylki-Szymańska
Journal:  Clin Rheumatol       Date:  2013-11-13       Impact factor: 2.980

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.